Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission

BMC Infectious Diseases
H GeorgesHauts de France endocarditis study group

Abstract

Right-sided infective endocarditis (RSIE) is an uncommon diagnosis accounting for less than 10% of cases of infective endocarditis. Optimal management for severely ill patients with RSIE remains challenging because few studies reported on management and outcome. The goal of our study was to determine outcome and associated prognostic factors in a population of ICU patients with a diagnosis of definite, active and severe RSIE. We performed a retrospective study in 10 French ICUs between January 2002 and December 2012. Main outcome was mortality at 30 days after ICU admission. Significant variables associated with 30-days mortality in the bivariate analysis were included in a logistic regression analysis. A total of 37 patients were studied. Mean age was 47.9 ± 18.4 years. Mean SAPS II, SOFA score and Charlson comorbidity index were 32.4 ± 17.4, 6.3 ± 4.4 and 3.1 ± 3.4, respectively. Causative pathogens, identified in 34 patients, were mainly staphylococci (n = 29). The source of endocarditis was a catheter related infection in 10 patients, intravenous drug abuse in 8 patients, cutaneous in 7 patients, urinary tract related in one patient and has an unknown origin in 7 patients. Vegetation size was higher than 20 mm for 14 patien...Continue Reading

References

May 1, 1989·American Heart Journal·P ChanB Segal
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Apr 16, 2003·Heart·Rob Moss, Brad Munt
Jul 2, 2003·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·William A ZoghbiUNKNOWN American Society of Echocardiography
Jan 28, 2005·Journal of Anesthesia·Shu-ichi YamashitaKaoru Honaga
Apr 7, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Michele MusciRoland Hetzer
Aug 20, 2008·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Myrna L ArmstrongFrank Cetta
Feb 12, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveHelen W Boucher
Mar 11, 2009·Archives of Internal Medicine·David R MurdochUNKNOWN International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators
Nov 13, 2009·Journal of Critical Care·Ghulam SaydainDonald P Levine
Dec 17, 2014·Medicine·Carlos OrtizJosé Alberto San Román
Sep 17, 2015·Circulation·Larry M BaddourUNKNOWN American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular
Jun 15, 2016·Médecine et maladies infectieuses·P Tattevin, J-L Mainardi
Jul 15, 2017·Annals of Cardiothoracic Surgery·Syed T HussainGösta B Pettersson

❮ Previous
Next ❯

Software Mentioned

SAS
RSIE

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.